Hematology/Oncology

Top Story

CDC annual report: Prescription drug use, obesity rates increase

June 28, 2017

Life expectancy is up and tobacco use is down, but there are still several concerning health indicators in the CDC’s 40th annual report on long-term trends in health and health care delivery of the nation between 1975 and 2015 which was delivered from the Secretary of HHS to President Donald Trump and Congress.

The report, Health, United States, 2016, describes birth rates and infant mortality, life expectancy and leading causes of death, health risk behaviors, health care utilization and insurance coverage and health expenditures. Highlights from the report include declines in cigarette smoking, increases in prescription drug use and changes in expenditures for hospitals and home health care. The CDC also investigated population changes that have affected patterns of disease and health care access and utilization since 1975.

Meeting News

Ixazomib combination confers durable responses in newly diagnosed myeloma

June 28, 2017
A combination regimen of ixazomib plus lenalidomide and dexamethasone conferred deep and durable responses among patients with newly diagnosed multiple myeloma…
Meeting News

Enzalutamide enhances PSA response, but not time to PSA progression, vs. abiraterone

June 28, 2017
CHICAGO – Enzalutamide demonstrated a greater PSA response among patients with metastatic, castration-resistant prostate cancer than abiraterone, although time to…

ACP: Supreme Court permitting parts of travel ban ‘creates uncertainty’

June 28, 2017
The June 26 Supreme Court decision to allow parts of President Trump’s travel ban on six Muslim-majority countries to take effect generates uncertainty and…
Meeting News

Enzyme activator could be ‘disease-altering’ treatment for pyruvate kinase deficiency

June 28, 2017
Enzyme activator AG-348 sustained hemoglobin increases in adults with pyruvate kinase deficiency, according to updated data from a phase 2 trial presented at the…
More News Headlines »
CME

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
More »
Video
Meeting News

VIDEO: Immunotherapy agent induces response in prostate cancer

June 20, 2017
More »
Resource Centers

CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement